Lost market share in Canada, a little too much, but gained as expected in the Pacific Rim and "other" places.

Other things to note in the 10Q that haven't been mentioned: there will be NO cost associated with SOX in the 4th qtr, and there was a substantial increase in R&D in the 3rd.

Also, it should be clear to everyone now that they have no intention of selling or eliminating the sensor product line, so let us put that to rest, I agree with management, that would be a stupid thing to do, and it aint gunna happen.

They got some cash, yes sir, zero debt, none, nada, and a cool mil on ice for the askin, chances are they will aquire some company, and in turn, eps growth...

Do you have a link for the patent infringement info on Biotel?